UBS reiterates Buy on California Resources stock, $78 target

UBS reiterated a Buy on California Resources and trimmed its price target to $78 from $82, while the stock has already risen 48% over the past year and trades at $62.15. The company said it has fully permitted operations for 2026, is working on 2027 permits, and targets a seven-rig maintenance program with $480 million to $500 million in capex. Q1 2026 EPS beat estimates at $0.88 versus $0.80, but revenue badly missed at $119 million versus $930.6 million, highlighting mixed operating momentum.

Analysis

CRC looks like a classic “good operator, bad headline” setup: the market is probably still anchoring on the revenue miss while underappreciating that the equity is really a leverage play on oil, permits, and capital efficiency. If permitting is accelerating faster than expected, the second-order effect is not just more volumes; it is lower regulatory optionality risk, which can justify a higher multiple on the reserve base because execution timing becomes more visible. That matters most over the next 6-18 months, when the market tends to reward de-risked growth plans more than near-term accounting noise.

The key asymmetry is that CRC’s upside is convex to sustained mid-cycle oil, but the downside is capped by the fact that the company is already speaking in terms of maintenance-mode capital and permit readiness. In a flat-to-down crude tape, the likely loser is not CRC alone but the broader California-weighted E&P cohort, because investors will extrapolate regulatory friction and hedge/PSC complexity across the peer set, compressing valuation multiples even if operational performance is fine. Conversely, if oil holds firm, CRC could become a relative winner versus lower-quality shale names that need constant reinvestment to defend output.

The contrarian read is that the market may be too focused on the revenue shortfall and not enough on cash margin durability. The bigger issue is that the stock has already rerated meaningfully, so incremental upside likely requires a credible 2027 permit milestone or a clear signal that the seven-rig program can be funded without stressing balance sheet flexibility. Absent that, the name may trade more like a high-beta oil derivative than a compounder, which argues for using options or pairs rather than outright chasing strength.

Key Decisions for Investors

• Long CRC vs. short a lower-quality E&P peer basket over 3-6 months: express the view that permit de-risking and margin expansion should outperform names with weaker execution visibility; target 15-20% relative upside with 8-10% stop on the spread.
• Buy CRC on pullbacks only, not strength, with a 1-2 month horizon: prefer entries after crude weakness or post-broad-market risk-off days; risk/reward improves if shares retrace 5-8% while the permit narrative remains intact.
• Use CRC call spreads for upside participation into the next operational update (3-6 months): defined-risk structure fits a stock that has already rerated; aim for 2:1+ payoff if management confirms 2027 permitting and maintenance-capex discipline.
• Hedge long CRC with a short on more operationally levered shale exposure if crude softens: CRC should hold up better if the market rotates toward de-risked balance sheets and regulatory clarity.
• Set a catalyst watch on 2027 permit progress and oil-price sensitivity over the next 6-12 months: if Brent weakens meaningfully, de-rate the thesis quickly because growth optionality becomes less valuable when management prioritizes maintenance over expansion.